Kimberly Gentile - 15 Sep 2026 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Reporting relationship: SVP, Clinical Operations
Issuer ticker: BHVN
Reported as of: 15 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Sep 2026, 18:15:10 UTC
Prior SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ George Clark, Attorney-in-Fact

Key filing fact

Kimberly Gentile filed Form 4 for Biohaven Ltd. (BHVN) on 17 Sep 2026.

Key facts

This page summarizes Kimberly Gentile's Form 4 filing for Biohaven Ltd. (BHVN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Sep 2026, 18:15.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001704186 Primary reporting owner

Gentile Kimberly

Relationship: SVP, Clinical Operations
Address: C/O BIOHAVEN LTD., 215 CHURCH STREET, NEW HAVEN
Signature: /s/ George Clark, Attorney-in-Fact
Signature date: 17 Sep 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BHVN transaction Derivative

Stock Options (Right to buy)

Award

Transaction value
Shares: +1,000
Change %
Price: $0.000000^*
Shares after: 1,000
Date: 15 Sep 2026
Ownership: By Son
Underlying class: Common Shares
Underlying amount: 1,000
Exercise price: $12.34
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares underlying this option vest in four equal installments on September 15, 2026, 2027, 2028 and 2029, subject to the Reporting Person's son's continuous service with the Issuer at each vesting date.

Footnote F2

Represents a stock option granted to the Reporting Person's son in connection with the commencement of his employment with the Issuer. The Reporting Person disclaims beneficial ownership of all securities held by her son, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.